NuCana Plc (NCNA)
1.98
-0.07
(-3.41%)
USD |
NASDAQ |
Jun 09, 16:00
1.98
0.00 (0.00%)
After-Hours: 20:00
NuCana SG&A Expense (Quarterly) : 2.113M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Mereo BioPharma Group Plc | 4.012M |
| Biodexa Pharmaceuticals Plc | -- |
| BioNTech SE | 176.43M |
| Silence Therapeutics Plc | 7.026M |
| Autolus Therapeutics Plc | 39.89M |